Navigation Links
PharmAthene Reports Third Quarter 2009 Financial and Operational Results

for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC").

Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at

-Tables Follow-

                             PHARMATHENE, INC.

                                               September 30,   December 31,
                                                       2009           2008
                                                       ----           ----

     Current assets:
       Cash and cash equivalents                 $4,188,272    $19,752,404
       Restricted cash                                    -     12,000,000
       Short-term investments                     7,382,329      3,190,912
       Accounts receivable                        5,055,107      8,890,077
       Other receivables (including
        unbilled receivables)                    13,668,072      1,391,512
       Prepaid expenses and other
        current assets                            1,765,758        917,125
                                                  ---------        -------
     Total current assets                        32,059,538     46,142,030

     Long-term restricted cash                 
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
(Date:1/15/2014)... Arizona (PRWEB) January 15, 2014 2013 ... for Scottsdale’s Brain State Technologies®. They saw continued independent ... Medical Center who were awarded a $1 million grant ... published in “Brain and Behavior” a peer reviewed journal, ...
(Date:1/14/2014)... 14, 2014 Carahsoft and CDS Federal ... 23, 2014 at 2pm EST (11am PST), “Natural Language ... focuses on how technology can turn raw, heterogeneous data ... government agencies. The online webinar will last approximately one ...
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... What do Saturn and flowers have in common? , ... recognizable in the natural world. Now, at an extremely ... of Massachusetts have created a unique set of conditions ... consistently assemble themselves into these and other complex shapes. ...
... (Nasdaq: FOLD ) announced today that Stephen ... resigned from the Company,s Board of Directors effective February ... of Amicus, board since 2004. About Amicus Therapeutics ... novel, oral therapeutics known as pharmacological chaperones for the ...
... Directors wishes to confirm to Stockholders that at its meeting ... 15 with effect from February 17, 2009. This initiative ... interests of keeping stockholders and other stakeholders informed the Board ... release the company from its United States Securities and Exchange ...
Cached Biology Technology:Sophisticated nano-structures assembled with magnets 2Sophisticated nano-structures assembled with magnets 3EESTECH Inc - Release From SEC Filing 2EESTECH Inc - Release From SEC Filing 3EESTECH Inc - Release From SEC Filing 4
(Date:4/24/2014)... A new study from investigators with the Autism ... on identifying genes associated with risk for autism, has ... (CNV) genetic testing offers an important tool in individualized ... by Autism Speaks, the world,s leading autism science and ... 50 research centers in 11 countries. The report, published ...
(Date:4/24/2014)... bacteria attack plants, they often inject harmful proteins ... suppress natural defenses. However, in some plants, bacteria ... a potential host. Now, researchers at the University ... that allows the bacteriaknown mostly for attacking tomatoesto ... natural anti-infective treatments that work with food-producing plants ...
(Date:4/24/2014)... shows that cells are more resilient in taking care ... missing critical components, cells can adapt and make copies ... a study published in this week,s Cell Reports ... showed that cells can grow normally without a crucial ... information is stored in DNA, which has to be ...
Breaking Biology News(10 mins):Autism Genome Project delivers genetic discovery 2Autism Genome Project delivers genetic discovery 3Plants send out signals attracting harmful bacteria, MU study finds 2Cell resiliency surprises scientists 2
... to improve nutrition, indoor air pollution, immunization coverage and ... significantly reduce child mortality from pneumonia, according to a ... Public Health. Researchers found that these strategies combined could ... reduce pneumonia deaths by more than 90 percent. Pneumonia ...
... found at health food stores could be the key to ... cause diarrhea, tooth decay and, in some severe cases, death. ... of proteins in both bacterial cells and human cells called ... shows that interrupting the way selenoproteins are made can halt ...
... from the perspective of cell biology, Nietzsche may have been ... make us stronger. In a review article published in the ... ( ), scientists from the Mayo Clinic explain how ... shut down old, diseased, or otherwise unwanted cells (called "apoptosis") ...
Cached Biology News:Cost-effective measures could stop child pneumonia deaths 2Newly discovered reactions from an old drug may lead to new antibiotics 2Scientists explain how 'death receptors' designed to kill our cells may make them stronger 2
... SUPERaseIn RNase Inhibitor (patent pending) is a ... noncovalently binds and inhibits the most common ... C, 1 and T1. SUPERaseIn can be ... could be problematic. It is ideal for ...
... RNaseOUT Recombinant Ribonuclease Inhibitor ... of pancreatic-type ribonucleases such as ... inhibitors RNaseOUT Recombinant Ribonuclease Inhibitor ... a molecular weight ~52 kDa. ...
... Core Kit contains all the ... assays on a wide range ... to dNTPs, the Core Kit ... used BIOLASE DNA polymerase, which ...
Biology Products: